Emtricitabine Capsule
Product Images NDC 69097-642

3 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine (NDC 69097-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (51787789 F222 42a1 B86b 8ca898722879 01)

Image (51787789 F222 42a1 B86b 8ca898722879 01)
Chemical structure of emtricitabine, illustrating the molecular arrangement including nitrogen, oxygen, fluorine atoms, and a thiofuranose ring, consistent with the active ingredient emtricitabine 200 mg oral capsule by Cipla USA Inc.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph showing the concentration of emtricitabine (µg/mL) in the blood over a 24-hour period, with time on the x-axis in hours and concentration on the y-axis on a logarithmic scale. The graph depicts a peak concentration around 2 hours followed by a gradual decline over 24 hours.*
FDA Label Image

Emtri-30s-bottle-label (Emtri 30s Bottle Label)

Emtri-30s-bottle-label (Emtri 30s Bottle Label)
Label for Emtricitabine Capsules, 200 mg, oral dosage form. The label states the product name, strength, and bottle count of 30 capsules. Manufactured by Cipla USA Inc., with instructions on storage at controlled room temperature and a caution to keep out of reach of children. Includes NDC 69097-642-02 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.